[25-NSE] SunLink Health Systems, Inc SEC Filing

Rhea-AI Filing Summary

SunLink Health Systems, Inc. submitted a Form 25 notifying the removal of its securities from NYSE American LLC. The filing names the issuer as SunLink Health Systems Inc and the exchange as NYSE AMERICAN LLC. The document is a formal notification under the Securities Exchange Act of 1934 that the class of securities will be struck from listing and/or registration. The filing includes the issuer's principal office address at 900 Circle 75 Parkway, Suite 1300, Atlanta, Georgia 30339 and a contact phone number 770-933-7000. The form cites compliance with the Exchange and SEC procedures for removal, referencing the applicable rule provisions for withdrawal.

Insights

Financial Analyst

TL;DR: Form 25 notifies removal of SSY securities from NYSE American; this is a material corporate action affecting liquidity and listing status.

The filing is a formal notice that SunLink Health Systems, Inc.'s class of securities will be removed from NYSE American LLC and/or its registration withdrawn. The document provides issuer identification, exchange name, and certifies that required Exchange and SEC procedures have been followed. It does not disclose the effective date, reason for delisting, or subsequent trading venue. For investors, delisting typically affects market access and liquidity; however, those specific impacts cannot be quantified from this filing alone because no financials, dates, or next steps are provided.

Corporate Governance Expert

TL;DR: The company filed a Form 25 to remove its securities from listing; governance implications are material but details are absent.

The Form 25 is a procedural filing confirming that NYSE American LLC and/or the issuer have followed the mechanics required to delist the specified class of securities. The filing lists the issuer's address and contact number but omits signatures, effective dates, and any explanatory disclosures. From a governance and disclosure perspective, the filing is material because it notifies stakeholders of a change in listing status, yet it lacks the contextual information (reasons, timelines, alternative listing plans) that investors and creditors would need to assess consequences.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-12607

Issuer:	SUNLINK HEALTH SYSTEMS INC
Exchange:	NYSE AMERICAN LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	900 Circle 75 Parkway, Suite 1300
	Atlanta	GEORGIA	30339
Telephone number:					770-933-7000

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NYSE AMERICAN LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-08-15	By	Anthony Sozzi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.